Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PCPTP1 Inhibitors

The chemical class known as PCPTP1 Inhibitors encompasses a diverse range of compounds that indirectly affect the activity of Protein Tyrosine Phosphatase Receptor Type R (PCPTP1). These inhibitors, rather than directly targeting PCPTP1, modulate various signaling pathways and cellular processes that are either upstream or downstream of PCPTP1's function. The interaction of these chemicals with specific signaling pathways provides a means to affect the activity of PCPTP1. This indirect influence is achieved through the modulation of kinase activity, phosphorylation status of proteins, and other cellular signaling mechanisms that are intertwined with the regulatory role of PCPTP1. The inhibitors in this class target pathways such as MAPK/ERK, MEK, JNK, p38 MAPK, PI3K/Akt, mTOR, tyrosine kinases, Src kinase, RAF, EGFR, FGFR, and BRAF signaling. Each of these pathways is integral to regulating cellular processes crucial for cell communication, growth, and differentiation, where PCPTP1 plays a significant role. The inhibitors operate by altering the cascading effects of these pathways, thereby influencing the functioning of PCPTP1. For instance, inhibitors affecting the MAPK/ERK pathway can alter the dynamics of cell signaling, thereby impacting PCPTP1's role in regulating this pathway. Similarly, compounds targeting MEK or the PI3K/Akt pathways affect key aspects of cellular signaling, which are crucial for the proper functioning of PCPTP1. Inhibitors of mTOR signaling have downstream effects on pathways where PCPTP1 is involved. Additionally, chemicals that inhibit tyrosine kinases, Src kinase, and RAF can have significant impacts on signaling pathways that intersect with PCPTP1's regulatory role. The broad spectrum of these inhibitors, targeting distinct but interconnected pathways, underscores the complex network of signaling processes that govern the activity of PCPTP1. By modulating these pathways, the inhibitors provide a means to indirectly affect the functioning of PCPTP1, thereby influencing the complex biological processes in which this protein is involved. This indirect approach to modulating PCPTP1's activity underscores the intricate interplay between various cellular signaling pathways and highlights the potential for influencing key regulatory mechanisms within the cell.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PTP Inhibitor V, PHPS1

314291-83-3sc-222226
10 mg
$243.00
12
(1)

PTP Inhibitor V, PHPS1, selectively targets the protein tyrosine phosphatase PCPTP1, exhibiting a unique binding affinity that stabilizes the enzyme's inactive conformation. This compound's distinct molecular architecture enables it to form critical hydrogen bonds and hydrophobic interactions, influencing downstream signaling pathways. Its kinetic profile reveals a rapid onset of inhibition, while its solubility characteristics enhance its accessibility to cellular targets, promoting effective engagement in biochemical assays.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits the MAPK/ERK pathway, which could indirectly affect PTPRR by altering its regulatory role in this pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, part of the MAPK pathway, which could influence PTPRR's activity in cell signaling regulation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAPK, a component of the MAPK pathway, potentially impacting PTPRR's regulatory function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits the PI3K/Akt pathway, which interacts with the MAPK pathway, potentially affecting PTPRR's activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR signaling, which could have downstream effects on the MAPK pathway and indirectly influence PTPRR.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Inhibits tyrosine kinases, which could affect the phosphorylation status of proteins in the MAPK pathway, indirectly influencing PTPRR.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Inhibits Src kinase, potentially affecting signaling pathways that intersect with PTPRR's regulatory role.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Inhibits RAF, a part of the MAPK pathway, potentially impacting the regulatory role of PTPRR in this pathway.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$85.00
$132.00
$287.00
$495.00
$3752.00
42
(0)

Inhibits EGFR, which can impact MAPK pathway signaling and indirectly influence PTPRR.